Contents

Current Medicinal Chemistry, Volume 16 - Number 25

A New Drug Candidate (GEMSP) for Multiple Sclerosis

, 16(25): 3203 - 3214

Arturo Mangas, Rafael Covenas, Dominique Bodet, Sebastien Duleu and Michel Geffard


DOI: 10.2174/092986709788803259




Recent Developments in the Chemistry of Thebaine and its Transformation Products as Pharmacological Targets

, 16(25): 3215 - 3242

Sandor Berenyi, Csaba Csutoras and Attila Sipos


DOI: 10.2174/092986709788803295




Receptor Dependent Multidimensional QSAR for Modeling Drug - Receptor Interactions

, 16(25): 3243 - 3257

Jaroslaw Polanski


DOI: 10.2174/092986709788803286




Thyroid Hormone Antagonists: Potential Medical Applications and Structure Activity Relationships

, 16(25): 3258 - 3266

Johan Malm, Mathias Farnegardh, Gary J. Grover and Paul W. Ladenson


DOI: 10.2174/092986709788803277




Doxorubicin: The Good, the Bad and the Ugly Effect

, 16(25): 3267 - 3285

Cristina Carvalho, Renato X. Santos, Susana Cardoso, Sonia Correia, Paulo J. Oliveira, Maria S. Santos and Paula I. Moreira


DOI: 10.2174/092986709788803312




New Therapeutic Targets for Drug Design Against Trypanosoma cruzi, Advances and Perspectives

, 16(25): 3286 - 3293

Gildardo Rivera, Virgilio Bocanegra-Garcia, Cynthia Ordaz-Pichardo, Benjamin Nogueda-Torres and Antonio Monge


DOI: 10.2174/092986709788803303




Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases

, 16(25): 3294 - 3321

Andras Toth, Lorand Kiss, Andras Varro and Peter P. Nanasi


DOI: 10.2174/092986709788803268




Blocking Receptor Protein Tyrosine Phosphatase β /ζ: A Potential Therapeutic Strategy for Parkinsons Disease

, 16(25): 3322 - 3329

Gonzalo Herradon and Laura Ezquerra


DOI: 10.2174/092986709788803240




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science